(Reuters) -Pfizer and Japanese firm Astellas' drug Padcev, combined with Merck's Keytruda, lowered the risk of tumor recurrence, progression or death in patients suffering from a type of bladder ...
Recognizing the sight of blood in urine, the most common first sign of bladder cancer, is often the impetus that leads people to a diagnosis. But for those with colorblindness, who usually have ...
TOKYO and NEW YORK, Oct. 18, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. (NYSE: PFE) today announced positive results from the ...
Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the cancer more resistant to treatment, according to new research from ...
HOUSTON – July 16, 2025 – Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the cancer more resistant to treatment, according to ...
The annual cancer statistics report from the National Cancer Institute (NCI) — which was published in the journal Cancer on Monday, April 21 — shows some signs of progress in America’s fight against ...
In the Phase 3 EV-304 trial, statistically significant improvements in overall survival and pathological complete response were also observed, with over half of patients having no detectable disease ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced KEYTRUDA® (pembrolizumab) plus ...
Everyday Health on MSN
8 treatments for metastatic bladder cancer pain
Bladder cancer can cause pain when it spreads to different areas of the body. From NSAIDs to nerve blocks, here are the ...
Hosted on MSN
Pat Finn dies at 60 after bladder cancer battle: Seinfeld and The Middle actor remembered
Television actor Pat Finn, best known for his memorable appearance on Sinefield and The Middle, has passed away at the age of 60 as he was battling with bladder cancer. The news of his death has heart ...
First and only combination regimen to improve survival when used before and after surgical cystectomy in cisplatin-ineligible patients with muscle-invasive bladder cancer Unprecedented survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results